1. Home
  2. BLCO vs GVA Comparison

BLCO vs GVA Comparison

Compare BLCO & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • GVA
  • Stock Information
  • Founded
  • BLCO 1853
  • GVA 1922
  • Country
  • BLCO Canada
  • GVA United States
  • Employees
  • BLCO N/A
  • GVA N/A
  • Industry
  • BLCO Ophthalmic Goods
  • GVA Military/Government/Technical
  • Sector
  • BLCO Health Care
  • GVA Industrials
  • Exchange
  • BLCO Nasdaq
  • GVA Nasdaq
  • Market Cap
  • BLCO 4.9B
  • GVA 4.1B
  • IPO Year
  • BLCO 2022
  • GVA 1990
  • Fundamental
  • Price
  • BLCO $13.99
  • GVA $93.85
  • Analyst Decision
  • BLCO Hold
  • GVA Strong Sell
  • Analyst Count
  • BLCO 13
  • GVA 1
  • Target Price
  • BLCO $15.83
  • GVA $76.00
  • AVG Volume (30 Days)
  • BLCO 785.5K
  • GVA 473.0K
  • Earning Date
  • BLCO 07-30-2025
  • GVA 07-31-2025
  • Dividend Yield
  • BLCO N/A
  • GVA 0.56%
  • EPS Growth
  • BLCO N/A
  • GVA 218.05
  • EPS
  • BLCO N/A
  • GVA 2.58
  • Revenue
  • BLCO $4,829,000,000.00
  • GVA $4,034,846,000.00
  • Revenue This Year
  • BLCO $6.97
  • GVA $7.95
  • Revenue Next Year
  • BLCO $5.48
  • GVA $6.03
  • P/E Ratio
  • BLCO N/A
  • GVA $36.28
  • Revenue Growth
  • BLCO 11.94
  • GVA 11.42
  • 52 Week Low
  • BLCO $10.45
  • GVA $61.13
  • 52 Week High
  • BLCO $21.69
  • GVA $105.20
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 69.08
  • GVA 62.30
  • Support Level
  • BLCO $12.02
  • GVA $91.71
  • Resistance Level
  • BLCO $14.35
  • GVA $95.31
  • Average True Range (ATR)
  • BLCO 0.46
  • GVA 1.75
  • MACD
  • BLCO 0.15
  • GVA -0.02
  • Stochastic Oscillator
  • BLCO 85.82
  • GVA 78.09

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

Share on Social Networks: